Outcomes of Juvenile Nasopharyngeal Angiofibroma Resection at Mayo Clinic: A 15-Year Analysis
Journal of Neurological Surgery Part B: Skull Base · 10.11.2026
DOI: 10.1055/a-2994-2898 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neurological Surgery Part B: Skull Base, erschienen am 10.11.2026. Verfasst von Hafsa Aden und 12 weiteren Autor:innen.
Abstract (Originalsprache)
Objective
To characterize surgical outcomes of juvenile nasopharyngeal angiofibroma (JNA) resections performed at Mayo Clinic over a 15-year period, with particular focus on the relationship between tumor stage, surgical approach, and outcomes.
Methods
Retrospective review of all patients with JNA who underwent resection at Mayo Clinic between January 2010 and January 2025. Demographics, presenting symptoms, University of Pittsburgh Medical Center (UPMC) stage, tumor volume, operative details, and outcomes were collected. Associations between tumor characteristics, surgical approach, and outcomes were analyzed.
Results
Forty-four male patients (mean age, 18.0 ± 5.1 years) were included; 43 (97.7%) underwent preoperative embolization. Most (81.8%) had exclusively endoscopic resections, 13.6% combined endoscopic–open, and 4.5% open. Residual disease occurred in 6.8% and recurrence in 6.8% of patients during follow-up. Patients with advanced UPMC stage (IV–V) were significantly more likely to require open/combined approaches (41.2% vs 3.8%, p=0.004), had longer operative times (482.0 vs 317.6 minutes, p=0.001), and higher blood loss (365.0 vs 100.0 mL, p=0.006). In contrast, tumor volume was not significantly associated with surgical outcomes. Recurrence rates did not differ significantly by stage or by presentation with primary versus recurrent disease.
Conclusion
In the modern era, most JNAs can be managed endoscopically with favorable outcomes. Advanced-stage tumors often necessitate combined or open approaches, with greater intraoperative morbidity but comparable outcomes. The UPMC staging system correlates more reliably with operative outcomes than tumor volume, underscoring its value for preoperative planning.
Zitieren
APA
Aden, H., Zalaquett, N. G. G., Olson, B. G., Schmidtman, D. C., Stokken, J., Wiedermann, J., Moore, E. J., O'brien, E., Eide, J., Gompel, J. J. V., Brinjikji, W., Cloft, H. J., & Pinheiro-Neto, C. (2026). Outcomes of Juvenile Nasopharyngeal Angiofibroma Resection at Mayo Clinic: A 15-Year Analysis. Journal of Neurological Surgery Part B: Skull Base. https://doi.org/10.1055/a-2994-2898
Vancouver
Aden H, Zalaquett NGG, Olson BG, Schmidtman DC, Stokken J, Wiedermann J, et al. Outcomes of Juvenile Nasopharyngeal Angiofibroma Resection at Mayo Clinic: A 15-Year Analysis. Journal of Neurological Surgery Part B: Skull Base. 2026. doi:10.1055/a-2994-2898
BibTeX
@article{Aden2026,
author = {Aden, Hafsa and Zalaquett, Nader Ghassan G and Olson, Brennan G. and Schmidtman, Daniel C and Stokken, Janalee and Wiedermann, Josh and Moore, Eric J. and O'brien, Erin and Eide, Jacob and Gompel, Jamie J van and Brinjikji, Waleed and Cloft, H. J. and Pinheiro-Neto, Carlos},
title = {Outcomes of Juvenile Nasopharyngeal Angiofibroma Resection at Mayo Clinic: A 15-Year Analysis},
journal = {Journal of Neurological Surgery Part B: Skull Base},
year = {2026},
doi = {10.1055/a-2994-2898}
}
EUVIMED